DEX Z-Code® submission for Molecular Diagnostic Tests (MDT)
Governs submission and billing requirements for molecular pathology and molecular diagnostic tests (MDT) billed on CMS-1500 and UB04 forms for UnitedHealthcare Commercial and Individual Exchange products; affects all providers submitting these claims.
Question and Answers Section (#8) added.
Transferred content to shared policy template and updated Application section to indicate this policy applies to all UnitedHealthcare Commercial and Individual Exchange benefit plans.
Question and Answers Section (#2) updated.
MDT Submission and Coverage Criteria
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.